Jackie Roseleur

Ms. Jackie Roseleur

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2023 in European Journal of Cardiovascular Nursing
Verified
Journal Article
Open access
PDF file
LBLemma N Bulto
Lemma N Bulto
JRJackie Roseleur
Jackie Roseleur
SNSara Noonan
Sara Noonan
Maria Alejandra Pinero de PlazaMaria Alejandra Pinero de Plaza
Maria Alejandra Pinero de Plaza
SCStephanie Champion
Stephanie Champion
JHJeroen M.H Hendriks
Jeroen M.H Hendriks
This review aimed to investigate the effectiveness of nurse-led interventions versus usual care on hypertension management, lifestyle behaviour, and patients’ knowledge of hypertension and associated risk factors. A systematic review with meta-analysis was conducted following Joanna Briggs Institute (JBI) guidelines. MEDLINE (Ovid), Emcare (Ovid), CINAHL (EBSCO), Cochrane library and ProQuest (Ovid) were searched from inception to 15th of February 2022. Randomised controlled trials (RCTs) examining the effect of nurse-led interventions on hypertension management were identified. Title and abstract, and full text screening, assessment of methodological quality, and data extraction were conducted by two independent reviewers using JBI tools. A statistical meta-analysis was conducted using STATA version 17.0. A total of 37 RCTs and 9,731 participants were included. The overall pooled data demonstrated that nurse-led interventions may reduce systolic blood pressure (Mean difference -4.66; 95% CI -6.69, -2.64; I2= 83.32; 31 RCTs; low certainty evidence) and diastolic blood pressure (Mean difference -1.91; 95% CI -3.06, -0.76; I2 = 79.35; 29 RCTs; low certainty evidence) compared to usual care. The duration of interventions contributed to the magnitude of blood pressure reduction. Nurse-led interventions had a positive impact on lifestyle behaviour and effectively modified diet and physical activity, but the effect on smoking and alcohol consumption was inconsistent. This review revealed beneficial effects of nurse-led interventions in hypertension management compared to usual care. Integration of nurse-led interventions in routine hypertension treatment and prevention services could play an important role in alleviating the rising global burden of hypertension. CRD42021274900

30 November 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
SPSharon M Parker
Sharon M Parker
MBMargo Linn Barr
Margo Linn Barr
NSNigel Stocks
Nigel Stocks
EDElizabeth Denney-Wilson
Elizabeth Denney-Wilson
NZNicholas Zwar
Nicholas Zwar
MHMark Harris
Mark Harris
Objectives To evaluate a multifaceted intervention on diet, physical activity and health literacy of overweight and obese patients attending primary care. Design A pragmatic two-arm cluster randomised controlled trial. Setting Urban general practices in lower socioeconomic areas in Sydney and Adelaide. Participants We aimed to recruit 800 patients in each arm. Baseline assessment was completed by 215 patients (120 intervention and 95 control). Intervention A practice nurse-led preventive health check, a mobile application and telephone coaching. Primary and secondary outcome measures Primary outcomes were measured at baseline, 6 and 12 months, and included patient health and eHealth literacy, weight, waist circumference and blood pressure. Secondary outcomes included changes in diet and physical activity, preventive advice and referral, blood lipids, quality of life and costs. Univariate and multivariate analyses of difference-in-differences (DiD) estimates for each outcome were conducted. Results At 6 months, the intervention group, compared with the control group, demonstrated a greater increase in Health Literacy Questionnaire domain 8 score (ability to find good health information; mean DiD 0.22; 95% CI 0.01 to 0.44). There were similar differences for domain 9 score (understanding health information well enough to know what to do) among patients below the median at baseline. Differences were reduced and non-statistically significant at 12 months. There was a small improvement in diet scores at 6 months (DiD 0.78 (0.10 to 1.47); p=0.026) but not at 12 months. There were no differences in eHealth literacy, physical activity scores, body mass index, weight, waist circumference or blood pressure. Conclusions Targeted recruitment and engagement were challenging in this population. While the intervention was associated with some improvements in health literacy and diet, substantial differences in other outcomes were not observed. More intensive interventions and using codesign strategies to engage the practices earlier may produce a different result. Codesign may also be valuable when targeting lower socioeconomic populations. Trial registration number Australian New Zealand Clinical Trials Registry (ACTRN 12617001508369) (http://www.ANZCTR.org.au/ACTRN12617001508369.aspx). Trial protocol The protocol for this trial has been published (open access; https://bmjopen.bmj.com/content/8/6/e023239).

18 January 2021 in Journal Of Hypertension
Verified
Journal Article
Closed access
JRJackie Roseleur
Jackie Roseleur
DGDavid A. Gonzalez-Chica
David A. Gonzalez-Chica
CBCarla O. Bernardo
Carla O. Bernardo
Benjamin P. GeislerBenjamin P. Geisler
Benjamin P. Geisler
JKJonathan Karnon
Jonathan Karnon
NSNigel P. Stocks
Nigel P. Stocks
Introduction: Hypertension is mostly managed in primary care. This study investigated the prevalence of diagnosed hypertension in Australian general practice and whether hypertension control is influenced by sociodemographic characteristics, duration since diagnosis or prescription of antihypertensive medications. Methods: Cross-sectional study using a large national database of electronic medical records of patients attending general practice in 2017 (MedicineInsight). Results: Of 1.2 million ‘regular’ patients (one or more consultations per year in every year from 2015 to 2017), 39.8% had a diagnosis of hypertension (95% confidence interval 38.7–40.9). Of these, 85.3% had their blood pressure (BP) recorded in 2017, and 54.9% (95% confidence interval 54.2–55.5) had controlled hypertension (5 years = 55.0%). Among recently diagnosed ‘regular’ patients, 59.2% had no record of being prescribed antihypertensive therapy in the last 6 months of the study, of which 44.3% had controlled hypertension. For those diagnosed more than 5 years ago, 37.4% had no record of being prescribed antihypertensive patients, and 56% had normal BP levels. Conclusion: Although the prevalence of hypertension varied by socidemographics, there were no differences in BP assessment or control by socioeconomic status. Hypertension control remains a challenge in primary care, and electronic medical records provide an opportunity to assess hypertension management.

14 January 2022 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
LELaura Catherine Edney
Laura Catherine Edney
JRJackie Roseleur
Jackie Roseleur
JGJodi Gray
Jodi Gray
BKBogda Koczwara
Bogda Koczwara
JKJonathan Karnon
Jonathan Karnon

2 May 2022 in Journal of Human Hypertension
Verified
Journal Article
Open access
PDF file
JRJackie Roseleur
Jackie Roseleur
DGDavid A. Gonzalez-Chica
David A. Gonzalez-Chica
JKJonathan Karnon
Jonathan Karnon
NSNigel P. Stocks
Nigel P. Stocks
Hypertension guidelines recommend that absolute cardiovascular disease (CVD) risk guide the management of hypertensive patients. This study aimed to assess the proportion of patients with diagnosed hypertension with sufficient data to calculate absolute CVD risk and determine whether CVD risk is associated with prescribing of antihypertensive therapies. This was a cross-sectional study using a large national database of electronic medical records of patients attending general practice in 2018 (MedicineInsight). Of 571,492 patients aged 45–74 years without a history of CVD, 251,733 [40.6% (95% CI: 39.8–41.2)] had a recorded hypertension diagnosis. The proportion of patients with sufficient recorded data available to calculate CVD risk was higher for patients diagnosed with hypertension [51.0% (95% CI: 48.0–53.9)] than for patients without a diagnosis of hypertension [38.7% (95% CI: 36.5–41.0)]. Of those patients with sufficient data to calculate CVD risk, 29.3% (95% CI: 28.1–30.6) were at high risk clinically, 6.0% (95% CI: 5.8–6.3) were at high risk based on their CVD risk score, 12.8% (95% CI: 12.5–13.2) at moderate risk and 51.8% (95% CI: 50.8–52.9) at low risk. The overall prevalence of antihypertensive therapy was 60.9% (95% CI: 59.3–62.5). Prescribing was slightly lower in patients at high risk based on their CVD risk score [57.4% (95% CI: 55.4–59.4)] compared with those at low [63.3% (95% CI: 61.9–64.8)] or moderate risk [61.8% (95% CI: 60.2–63.4)] or at high risk clinically [64.1% (95% CI: 61.9–66.3)]. Guideline adherence is suboptimal, and many patients miss out on treatments that may prevent future CVD events.

7 November 2023 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
JRJackie Roseleur
Jackie Roseleur
LELaura Catherine Edney
Laura Catherine Edney
JJJayda Jung
Jayda Jung
JKJonathan Karnon
Jonathan Karnon
Purpose: Improved health outcomes for individuals ever diagnosed with cancer require comprehensive, coordinated care that addresses their supportive care needs. Implementing interventions to address these is confounded by a lack of evidence on population needs and a large pool of potential interventions. This systematic review estimates the point prevalence of different supportive care needs stratified by the tool used to measure needs and cancer type in Australia. Methods: We searched MEDLINE, Embase, and Scopus from 2010 to April 2023 to identify relevant studies published on the prevalence of supportive care needs in Australia. Results: We identified 35 studies that met the inclusion criteria. The highest prevalent unmet need across all cancers was ‘fear of cancer spreading’ (20.7%) from the Supportive Care Needs Survey Short-Form 34 (SCNS-SF34), ranging from 9.4% for individuals ever diagnosed with haematological cancer to 36.3% for individuals ever diagnosed with gynaecological cancer, and ‘concerns about cancer coming back’ (17.9%) from the Cancer Survivors’ Unmet Needs (CaSUN), ranging from 9.7% for individuals ever diagnosed with prostate cancer to 37.8% for individuals ever diagnosed with breast cancer. Two studies assessed needs in Aboriginal and Torres Strait Islander populations, reporting the highest needs for financial worries (21.1%). Conclusions: Point prevalence estimates presented here, combined with estimates of the costs and effects of potential interventions, can be used within economic evaluations to inform evidence-based local service provision to address the supportive care needs of individuals ever diagnosed with cancer. Implications for Cancer Survivors: Local health services can use local evidence to prioritise the implementation of interventions targeted at unmet needs.